Keywords: fda, approves, amgen, new-generation, filgrastim, product, neulasta

FDA approves Amgen's new-generation filgrastim product, Neulasta

Article | 11 February 2002

Print This

Amgen has been granted approval in the USA for Neulasta(pegfilgrastim), a new version of Neupogen (filgrastim), its blockbuster treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in